Reassessing Treatment-Resistant Depression: A Checklist

When Depression Will Not Lift: A Reassessment Roadmap

Treatment-resistant depression is a term that may be used when depression has not improved after one or more antidepressant trials. This can be discouraging, but it does not determine what will happen next. It often indicates a need for a structured review of the diagnosis, prior treatment, medical contributors, and current level of support.

A careful reassessment may identify factors that can affect treatment response, including medical conditions, sleep disruption, medication adverse effects, substance use, or unrecognized bipolar-spectrum symptoms. Limited improvement with prior treatment is clinical information, not a personal failure. It can help guide a more detailed psychiatric and medical review.

Resova Health is a physician-led, psychiatry-first practice focused on psychiatric evaluation, diagnosis, and longitudinal medication management, primarily through telemedicine. Telepsychiatry can support structured evaluation, medication management, follow-up, and care coordination. In-person services are offered only where specified, including psychiatric evaluations related to advanced treatment options at the Virginia location. Resova Health may also provide psychiatric evaluation, education, eligibility assessment, and referral for TMS and ketamine when clinically appropriate.

Medical Workup That Often Gets Missed

Before treatment-resistant depression is considered, clinicians may review whether a medical condition is contributing to depressive symptoms or limiting treatment response. Several physical conditions can overlap with low mood, fatigue, slowed thinking, and poor concentration. When clinically indicated, addressing these factors may inform psychiatric treatment planning.

Key components of a medical workup may include:

Thyroid function testing when clinically indicated
Sleep evaluation when symptoms suggest a sleep disorder
Blood counts and selected nutrient testing
Review of chronic medical conditions and current treatment

Thyroid dysfunction can affect mood, energy, sleep, weight, and concentration. Hypothyroidism may be associated with fatigue, low mood, weight changes, and slowed thinking, while hyperthyroidism can contribute to anxiety, irritability, and sleep disturbance. Laboratory testing and primary care follow-up can help determine whether thyroid findings require treatment or may be relevant to psychiatric medication planning. Other hormonal testing is generally considered when symptoms, history, or examination findings support it.

Sleep is also clinically relevant. Obstructive sleep apnea and chronic insomnia can contribute to daytime fatigue, low mood, and difficulty concentrating. Loud snoring, witnessed breathing pauses, gasping during sleep, unrefreshing sleep, and excessive daytime sleepiness may warrant discussion with a primary care clinician or sleep specialist. Sleep-related care may include:

Behavioral sleep strategies
Review of psychiatric medication timing and adverse effects
Referral for sleep testing when indicated

Anemia, vitamin B12 or folate deficiency, vitamin D deficiency, and chronic inflammatory, cardiac, or other medical conditions may also affect energy and mood in some patients. Collaboration with primary care clinicians or relevant specialists can help place medical findings in context. Resova Health’s role in telepsychiatric care is to incorporate relevant medical information into psychiatric assessment and medication-management planning.

Looking Beyond Unipolar Depression: Bipolar and Mixed Clues

Depression that has not responded as expected may warrant reconsideration of the diagnosis. Some individuals initially diagnosed with unipolar depression may have bipolar-spectrum illness or depressive episodes with mixed features. Diagnostic clarification can affect medication selection, monitoring, and treatment goals.

Bipolar and mixed-feature screening may include:

Past periods of unusually elevated, expansive, or irritable mood
Decreased need for sleep without subsequent fatigue
Episodes of impulsive spending, risky behavior, or racing thoughts
Family history of bipolar disorder

Mixed features can be difficult to recognize. A person may experience depression and hopelessness while also feeling restless, agitated, unusually energized, irritable, or unable to slow their thoughts. In some clinical situations, antidepressants may provide limited benefit or may contribute to mood instability. Medication decisions should be individualized and monitored by a qualified clinician.

Seasonal changes may add further context. Some people experience lower mood as daylight, routines, or activity levels change. For others, seasonal shifts may coincide with increased energy, irritability, or more pronounced mood variation. A longitudinal review is often more informative than a single visit when evaluating these patterns.

A psychiatric evaluation may include:

Detailed mood timelines over months or years
Structured screening tools for bipolar-spectrum symptoms
Input from family members or close supports, when available and appropriate

Resova Health’s physician-led, psychiatry-first model includes diagnostic clarification and longitudinal medication management. When clinically appropriate, care may include medication adjustment, referral for a higher level of care, or psychiatric evaluation for advanced treatment options such as TMS. In-person TMS and ketamine infusion therapy are available at the Virginia location only.

Substances, Medications, and How the Body Handles Treatment

Depression may appear resistant when substance use, medication effects, or medication-taking patterns are affecting symptoms or treatment response. Alcohol, cannabis, other substances, and some prescription or over-the-counter medications can affect sleep, energy, anxiety, mood stability, and the tolerability of psychiatric medications.

Common contributors may include:

Regular alcohol use, particularly when it disrupts sleep or worsens mood
Cannabis use that may affect motivation, anxiety, or concentration
Sedatives or certain pain medications associated with fatigue or cognitive slowing
Stimulants, energy products, or decongestants that may interfere with sleep

Some nonpsychiatric medications, including certain steroids, hormonal agents, and neurologic medications, may affect mood or interact with psychiatric prescriptions. A medication review should include prescription medications, over-the-counter products, supplements, and other substances.

Adherence and absorption are also relevant. Missed doses, inconsistent timing, and abrupt discontinuation can affect both symptoms and medication tolerability. These patterns are common and should be reviewed without judgment. Gastrointestinal conditions, a history of bariatric surgery, and drug interactions may also alter medication absorption or metabolism.

Telepsychiatry can support ongoing review of these factors. Resova Health’s approach includes:

Structured medication reviews during follow-up visits
Ongoing assessment of adverse effects, adherence, and potential benefit
Planned medication adjustments when clinically appropriate

Careful review of dose, timing, interactions, and treatment history may help distinguish possible treatment resistance from factors that can be addressed through medication management or coordinated medical care.

When Treatment-Resistant Depression Requires Higher Care

Outpatient medication management is not appropriate for every clinical situation. Active suicidal intent, recent serious self-harm, psychosis, or inability to meet basic needs may require urgent emergency evaluation or a higher level of care. This article is not a substitute for emergency assessment or crisis guidance.

Clinical concerns that may indicate a need for higher-level care include:

Active suicidal thoughts with plan or intent
Recent suicide attempt or serious self-harm
Inability to meet basic needs, including eating, hygiene, or safe shelter
Marked functional decline at work, school, or home
Psychotic symptoms, such as hearing voices or fixed false beliefs

Depending on the circumstances, emergency evaluation, inpatient hospitalization, partial hospitalization, or intensive outpatient treatment may be indicated. The immediate priority in these situations is safety and stabilization, followed by longer-term treatment planning.

For some patients who have completed multiple adequate medication trials and a thorough reassessment, psychiatric evaluation may include discussion of advanced options such as TMS or ketamine. Resova Health’s role is limited to psychiatric evaluation, education, eligibility assessment, referral, and care coordination. This may include:

Review of prior treatment trials and current symptoms
Education about potential benefits, limitations, and risks
Assessment of clinical eligibility and appropriateness
Referral when clinically appropriate

In-person TMS and ketamine infusion therapy are available at the Virginia location only. Resova Health does not present these services as a substitute for emergency or higher-level care. When other clinicians or programs are involved, care coordination may help clarify treatment roles and follow-up plans. Telepsychiatric follow-up may continue after higher-level or advanced treatment interventions when feasible and clinically appropriate, with attention to medication management and relapse prevention.

Taking the Next Step in Your Reassessment

Persistent depression after treatment trials may warrant a more detailed reassessment. Relevant contributors can include medical findings, bipolar-spectrum symptoms, substance effects, medication interactions, adherence concerns, sleep disruption, or safety needs. A lack of expected improvement is a reason to review the clinical picture carefully rather than draw conclusions from a single treatment outcome.

A psychiatric reassessment commonly includes a targeted medical review, screening for bipolar and mixed features, evaluation of substances and medication interactions, review of medication adherence and tolerability, and assessment of safety and level-of-care needs. Resova Health provides physician-led psychiatric evaluation and longitudinal medication management primarily through telemedicine, using structured interviews, medication reviews, follow-up, and coordination with other clinicians when needed. Results vary, and a systematic reassessment may help clarify appropriate next steps.

Next Steps for Psychiatric Evaluation and Medication Management

Patients and referring clinicians may request a psychiatric evaluation or medication-management consultation when clinically appropriate. Resova Health provides psychiatry-first assessment, diagnosis, longitudinal medication management, and care coordination primarily through telemedicine. To request an appointment, provide available clinical history, current medications, prior treatment information, and relevant referral records when applicable.

Important Safety and Scope Information

This checklist is for general education and does not diagnose treatment-resistant depression or replace an individualized evaluation. Medication changes, testing, referrals, and treatment decisions require a licensed clinician who considers the patient’s history, current symptoms, medical conditions, medications, location, and applicable law. Seek urgent in-person or emergency care for immediate danger, severe symptoms, or inability to stay safe. In the United States, call or text 988 for crisis support.